Antiviral | EC50 ratio | Phenotype | Strain | Source | Marker | Assay | Reference |
---|---|---|---|---|---|---|---|
Ganciclovir | 6.20 | High level resistance | Recombinant | Details | Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. (May 2016) | ||
Cidofovir | 0.87 | No resistance | Recombinant | Details | Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. (May 2016) | ||
Foscarnet | 4.70 | Intermediate level resistance | Recombinant | Details | Contrasting effect of new HCMV pUL54 mutations on antiviral drug susceptibility: Benefits and limits of 3D analysis. (May 2016) |
Mutant | Resistances |
---|---|
D515E |
Ganciclovir:
|
D515E |
Cidofovir:
|
D515E |
Foscarnet:
|
D515G |
|